Page 558 - Williams Hematology ( PDFDrive )

532 Part VI: The Erythrocyte Chapter 35: Aplastic Anemia: Acquired and Inherited 533

transplantation, but this step, if successful, does not correct somatic 32. Nistico, A, Young, NS: Gamma-interferon gene expression in the bone marrow of
abnormalities, only the hematopoietic and immunologic defect. The patients with aplastic anemia. Ann Intern Med 120:463, 1994.
restoration of robust lymphohematopoiesis by transplantation may 33. Zoumbos N, Gascon P, Djeu J, Young NS: Interferon is a mediator of hematopoietic
suppression in aplastic anemia in vitro and possibly in vivo. Proc Natl Acad Sci U S A
decrease their propensity to undergo clonal evolution to a clonal mye- 82:188, 1985.
loid or, in some cases, lymphoid disorder. 34. Sloand E, Kim S, Maciejewski JP, et al: Intracellular interferon-gamma in circulating
and marrow T cells detected by flow cytometry and the response to immunosuppres-
sive therapy in patients with aplastic anemia. Blood 100:1185, 2002.
REFERENCES 35. Solomou EE, Keyvanfar K, Young NS: T-bet, a Th1 transcription factor, is up-regulated
in T cells from patients with aplastic anemia. Blood 107:3983, 2006.
36. Risitano AM, Maciejewski JP, Green S, et al: In vivo dominant immune responses in
1. Incidence of aplastic anemia: The relevance of diagnostic criteria. By the International aplastic anaemia: Molecular tracking of putatively pathogenetic T-cell clones by TCR
Agranulocytosis and Aplastic Anemia Study. Blood 70:1718, 1987. beta-CDR3 sequencing. Lancet 364:355, 2004.
2. Ehrlich P: Über einen Fall von Anamie mit Bemerkungen über regenerative Verander- 37. Solomou EE, Rezvani K, Mielke S, et al: Deficient CD4+ CD25+ FOXP3+ T regulatory
ungen des Knochenmarks. Charite Ann 13:300, 1888. cells in acquired aplastic anemia. Blood 110:1603, 2007.
3. Chauffard M: Un cas d’anémie pernicieuse aplastique. Bull Soc Med Hop Paris 21:313, 38. Fujisaki J, Wu J, Carlson AL, et al: In vivo imaging of Treg cells providing immune
1904. privilege to the haematopoietic stem-cell niche. Nature 474:216, 2011.
4. Scott JL, Cartwright GE, Wintrobe MM: Acquired aplastic anemia: An analysis of thir- 39. Chen J, Ellison FM, Eckhaus MA, et al: Minor antigen h60-mediated aplastic anemia is
ty-nine cases and review of the pertinent literature. Medicine (Baltimore) 38:119, 1959. ameliorated by immunosuppression and the infusion of regulatory T cells. J Immunol
5. Thomas ED, Storb R, Fefer A, et al: Aplastic anemia treated by bone marrow transplan- 178:4159, 2007.
tation. Lancet 1: 284, 1972. 40. Hirano N, Butler MO, Von Bergwelt-Baildon MS, et al: Autoantibodies frequently
6. Thomas ED, Storb R, Giblett B, et al: Recovery from aplastic anemia following attempted detected in patients with aplastic anemia. Blood 102:4567, 2003.
marrow transplantation. Exp Hematol 4:97, 1976. 41. Young, NS: Current concepts in the pathophysiology and treatment of aplastic anemia.
7. Champlin RE, Feig SA, Sparkes RS, Gale RP: Bone marrow transplantation from iden- Hematology Am Soc Hematol Educ Program 2013:76, 2013.
tical twins in the treatment of aplastic anaemia: Implication for the pathogenesis of the 41a. Townsley DM, Dumitriu B, Young NS. Bone marrow failure and the telomeropathies.
disease. Br J Haematol 56:455, 1984. Blood 124:2775, 2014.
8. Speck B, Gluckman E: Treatment of aplastic anemia by antilymphocyte globulin with 42. Smick K, Condit PK, Proctor RL, Sutcher V: Fatal aplastic anemia: An epidemiological
and without allogeneic bone marrow infusions. Lancet 2:1145, 1977. study of its relationship to the drug chloramphenicol. J Chronic Dis 17:899, 1964.
9. Mary JY, Baumelou E, Guiguet M: Epidemiology of aplastic anemia in France: A pro- 43. Modan B, Segal S, Shani M, Sheba C: Aplastic anemia in Israel: Evaluation of the eti-
spective multicenter study. Blood 75:1646, 1990. ological role of chloramphenicol on a community-wide basis. Am J Med Sci 270:441,
10. Montané E, Ibáñez L, Vidal X, et al: Epidemiology of aplastic anemia: A prospective 1975.
multicenter study. Haematologica 93:518, 2008. 44. Yunis AA Chloramphenicol toxicity: 25 years of research. Am J Med 87:44N, 1989.
11. Maluf EM, Pasquini R, Eluf JN, et al: Aplastic anemia in Brazil: Incidence and risk 45. Custer RP: Aplastic anemia in soldiers treated with Atabrine (quinacrine). Am J Med Sci
factors. Am J Hematol 71:268, 2002. 212:211, 1946.
12. McCahon E, Tang K, Rogers PC, et al: The impact of Asian descent on the incidence of 46. Best WR: Drug-associated blood dyscrasias. JAMA 185:286, 1963.
acquired severe aplastic anaemia in children. Br J Haematol 121:170, 2003. 47. Risks of agranulocytosis and aplastic anemia. A first report of their relation to drug
13. Chongli Y, Ziaobo Z: Incidence survey of aplastic anemia in China. Chin Med Sci J use with special reference to analgesics. The International Agranulocytosis and Aplastic
6:203, 1991. Anemia Study. JAMA 256:1749, 1986.
14. Issaragrisil S: Epidemiology of aplastic anemia in Thailand. Thai Aplastic Anemia Study 48. Retsagi G, Kelly JP, Kaufman DW: Risk of agranulocytosis and aplastic anaemia in rela-
Group. Int J Hematol 70:137, 1999. tion to use of antithyroid drugs. International Agranulocytosis and Aplastic Anaemia
15. Yong AS, Goh AS, Rahman M, et al: Epidemiology of aplastic anemia in the state of Study. BMJ 297:262, 1988.
Sabah, Malaysia. Med J Malaysia 53:59, 1998. 49. Anti-infective drug use in relation to the risk of agranulocytosis and aplastic anemia. A
16. Issaragrisil S, Kaufman DW, Anderson T, et al: The epidemiology of aplastic anemia in report from the International Agranulocytosis and Aplastic Anemia Study. Arch Intern
Thailand. Blood 107:1299, 2006. Med 149:1036, 1989.
17. Young NS, Kaufman DW: The epidemiology of acquired aplastic anemia. Haematolog- 50. Kelly JP, Kaufman DW, Shapiro S: Risks of agranulocytosis and aplastic anemia in rela-
ica 93:489, 2008. tion to the use of cardiovascular drugs: The International Agranulocytosis and Aplastic
18. Yin SN, Hayes RB, Linet MS, et al: A cohort study of cancer among benzene-exposed Anemia Study. Clin Pharmacol Ther 49:330, 1991.
workers in China: Overall results. Am J Ind Med 29:227, 1996. 51. Kaufmann DW, Kelly JP, Jurgelon JM, et al: Drugs in the aetiology of agranulocytosis
19. Locasciulli A, Bacigalupo A, Bruno B, et al: Hepatitis-associated aplastic anaemia: Epi- and aplastic anaemia. Eur J Haematol 57(Suppl):23, 1996.
demiology and treatment results obtained in Europe. A report of The EBMT aplastic 52. Baumelou E, Guiguet M, Mary JY, et al: Epidemiology of aplastic anemia in France: A
anaemia working party. Br J Haematol 149:890, 2010. case control study. I. Medical history and medication use. Blood 81:1471, 1993.
20. Kagan WA, Ascensao J, Pahwa R, et al: Aplastic anemia: Presence in human bone mar- 53. Bithell TC, Wintrobe MM: Drug-induced aplastic anemia. Semin Hematol 4:194, 1967.
row of cells that suppress myelopoiesis. Proc Natl Acad Sci U S A 73:2890, 1976. 54. Williams DM, Lynch RE, Cartwright GE: Drug-induced aplastic anemia. Semin Hema-
21. Maciejewski JP, Anderson S, Katevas P, Young NS: Phenotypic and functional analysis tol 10:195, 1973.
of bone marrow progenitor cell compartment in bone marrow failure. Br J Haematol 55. Tonkonow B, Hoffman R: Aplastic anemia and cimetidine. Arch Intern Med 140:1123,
87:227, 1994. 1980.
22. Scopes J, Bagnara M, Gordon-Smith EC, et al: Haemopoietic progenitor cells are 56. Volkin RL, Shadduck RK, Winkelstein A, et al: Potentiation of carmustine-cranial-irradiation-
reduced in aplastic anaemia. Br J Haematol 86:427, 1994. induced myelosuppression by cimetidine. Arch Intern Med 142:243, 1982.
23. Maciejewski JP, Selleri C, Sato T, et al: A severe and consistent deficit in marrow and 57. Khan HA: Benzene toxicity: A consolidated short review of human and animal studies.
circulating primitive hematopoietic cells (long-term culture-initiating cells) in acquired Hum Exp Toxicol 26:677, 2007.
aplastic anemia. Blood 88:1983, 1996. 58. Smith MT: Overview of benzene-induced aplastic anemia. Eur J Haematol 60:107, 1996.
24. Young NS, Scheinberg P, Calado RT: Aplastic anemia. Curr Opin Hematol 15:162, 2008. 59. Snyder R: Benzene and leukemia. Crit Rev Toxicol 32:155, 2002.
25. Sugimori C, Yamazaki H, Feng X, et al: Roles of DRB1 *1501 and DRB1 *1502 in the 60. Fleming LE, Timmeny MA: Aplastic anemia and pesticides. An etiologic association?
pathogenesis of aplastic anemia. Exp Hematol 35:13, 2007. J Occup Med 35:1106, 1993.
26. Young NS, Calado RT, Scheinberg P: Why does the bone marrow fail in Fanconi ane- 61. Rugman FP, Cosstick R: Aplastic anaemia associated with organochlorine pesticide:
mia? Blood 108:2509, 2006. Case reports and review of evidence. J Clin Pathol 43:98, 1990.
27. Young NS, Maciejewski J: Mechanisms of disease: The pathophysiology of acquired 62. Muir KR, Chilvers CE, Harriss C, et al: The role of occupational and environmental
aplastic anemia. N Engl J Med 336:1365, 1997. exposures in the aetiology of acquired severe aplastic anaemia: A case control investi-
28. Laver J, Castro-Malaspina H, Kernan NA, et al: In vitro interferon-gamma production gation. Br J Haematol 123:906, 2003.
by cultured T-cells in severe aplastic anaemia: Correlation with granulomonopoietic 63. Valdez Salas B, Garcia Duran EI, Wiener MS: Impact of pesticides use on human health
inhibition in patients who respond to anti-thymocyte globulin. Br J Haematol 69:545, in Mexico: A review. Rev Environ Health 15:399, 2000.
1988. 64. Ahamed M, Anand M, Kumar A, Siddiqui MK: Childhood aplastic anaemia in Luc-
29. Gascon P, Zoumbos NC, Scala G, et al: Lymphokine abnormalities in aplastic anemia: know, India: Incidence, organochlorines in the blood and review of case reports follow-
Implications for the mechanism of action of antithymocyte globulin. Blood 65:407, ing exposure to pesticides. Clin Biochem 39:762, 2006.
1985. 65. Rauch AE, Kowalsky SF, Lesar TS, et al: Lindane (Kwell)-induced aplastic anemia. Arch
30. Hinterberger W, Adolf G, Bettelheim P, et al: Lymphokine overproduction in severe Intern Med 150:2393, 1990.
aplastic anemia is not related to blood transfusions. Blood 74:2713, 1989. 66. Roberts HJ: Pentachlorophenol-associated aplastic anemia, red cell aplasia, leukemia
31. Shinohara K, Ayame H, Tanaka M, et al: Increased production of tumor necrosis factor and other blood disorders. J Fla Med Assoc 77:86, 1990.
alpha by peripheral blood mononuclear cells in the patients with aplastic anemia. Am J 67. Prager D, Peters C: Development of aplastic anemia and the exposure to Stoddard sol-
Hematol 37:75, 1991. vent. Blood 35:286, 1970.

Kaushansky_chapter 35_p0513-0538.indd 533 9/19/15 12:24 AM